Stocks and InvestingStocks and Investing
Fri, June 21, 2024
Thu, June 20, 2024
Wed, June 19, 2024
Tue, June 18, 2024

Geulah Livshits Maintained (TSHA) at Strong Buy and Held Target at $7 on, Jun 18th, 2024


Published on 2024-10-28 11:59:39 - WOPRAI, Geulah Livshits
  Print publication without navigation


Geulah Livshits of Chardan Capital, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $7 on, Jun 18th, 2024.

Geulah has made no other calls on TSHA in the last 4 months.



There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 0 agree with Geulah's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Geulah


  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $7 on, Monday, June 17th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Tuesday, May 28th, 2024
  • Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $8 on, Tuesday, May 14th, 2024
  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $9 on, Tuesday, April 9th, 2024
  • Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $7 on, Thursday, March 21st, 2024
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Wednesday, March 20th, 2024